Vasoactive intestinal peptide modification at position 22 allows discrimination between receptor subtypes

European Journal of Pharmacology

Volumn 348, Issue 1, 1998, Pages 95-99

  Gourlet, Philippe ^a   Vandermeers Piret, Marie Claire ^a   Rathé, Jean ^a   De Neef, Philippe ^a   Cnudde, Johnny ^a   Robberecht, Patrick ^a   Waelbroeck, Magali ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

VIP (vasoactive intestinal peptide) analog; VIP1 PACAP receptor; VIP2 PACAP receptor

Indexed keywords

GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; RECEPTOR SUBTYPE; SECRETIN; SECRETIN DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL LINE; CHINESE HAMSTER; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; RECEPTOR AFFINITY;

AMINO ACID SEQUENCE; ANIMALS; CHO CELLS; CRICETINAE; MEMBRANES; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; PEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY HORMONE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032077079     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00133-2     Document Type: Article

References (24)

1. Ambrosius D., Casaretto M., Gerardy-Schahn R., Saunders D., Brandenburg D., Zahn H. Peptide analogues of the anaphylatoxin C3a; syntheses and properties. Biol. Chem. Hoppe-Seyler. 370:1989;217-227.
2. Ciccarelli E., Vilardaga J.-P., De Neef P., Di Paolo E., Waelbroeck M., Bollen A., Robberecht P. Properties of the VIP-PACAP type II receptor stably expressed in CHO cells. Regul. Pept. 54:1994;397-407.
3. Couvineau A., Rouyer-Fessard C., Darmoul D., Maoret J.-J., Carrero I., Ogier-Denis E., Laburthe M. Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun. 200:1994;769-774.
4. 2 recombinant receptors. Regul. Pept. 62:1996;125-130.
5. Gourlet P., Vandermeers A., Vandermeers-Piret M.-C., De Neef P., Robberecht P. Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy. Int. J. Pept. Protein Res. 48:1996;391-396.
6. 2 receptor subclass. Peptides. 18:1997;403-408.
7. 1 receptor agonists. Peptides. 18:1997;1539-1545.
8. 1 receptor. Peptides. 18:1997;1555-1560.
9. 2 receptors. Ann. N.Y. Acad. Sci. (in press).
10. Inagaki N., Yoshida H., Mizuta M., Mizuno N., Fujii Y., Gonoi T., Miyazaki J.-I., Seino S. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2679-2683.
11. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8:1992;811-819.
12. 2 receptor: molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334:1993;3-8.
13. O'Donnell M., Garippa R.J., O'Neill N.C., Bolin D.R., Cottrell J.M. Structure-activity studies of vasoactive intestinal polypeptide. J. Biol. Chem. 266:1991;6389-6392.
14. O'Donnell M., Garippa R.J., Rinaldi N., Selig W.M., Simko B., Renzetti L., Tannu S.A., Wasserman M.A., Welton A., Bolin D.R. RO 25-1553: a novel, long-acting vasoactive intestinal peptide agonist: I. In vitro and in vivo bronchodilator studies. J. Pharmacol. Exp. Ther. 270:1994;1282-1288.
15. O'Donnell M., Garippa R.J., Rinaldi N., Selig W.M., Tocker J.E., Tannu S.A., Wasserman M.A., Welton A., Bolin D.R. RO 25-1553: a novel, long-acting vasoactive intestinal peptide agonist: II. Effect on in vitro and in vivo models of pulmonary anaphylaxis. J. Pharmacol. Exp. Ther. 270:1994;1289-1294.
16. Robberecht P., Tatemoto K., Chatelain P., Waelbroeck M., Delhaye M., Taton G., De Neef P., Camus J.C., Heuse D., Christophe J. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes: a comparison in man, rat, mouse and guinea pig. Regul. Pept. 4:1982;241-250.
17. 4]PHI), a highly selective vasoactive intestinal peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes. Eur. J. Biochem. 165:1987;243-249.
18. Robberecht P., Waelbroeck M., De Neef P., Camus J.C., Coy D.H., Christophe J. Pharmacological characterization of VIP receptors in human lung membranes. Peptides. 9:1988;339-345.
19. Robberecht P., De Neef P., Gourlet P., Cauvin A., Coy D.H., Christophe J. Pharmacological characterization of the novel helodermin/VIP receptor present in human SUP-T1 lymphoma cell membranes. Regul. Pept. 26:1989;117-126.
20. Robberecht P., Gourlet P., Vertongen P., Svoboda M. Characterization of the VIP receptor from SUP-T1 lymphoblasts. Adv. Neuroimmunol. 6:1996;49-57.
21. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal. Biochem. 58:1974;541-548.
22. Svoboda M., Tastenoy M., Van Rampelbergh J., Goossens J.-F., De Neef P., Waelbroeck M., Robberecht P. Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem. Biophys. Res. Commun. 205:1994;1617-1624.
23. Usdin T.B., Bonner T.I., Mezey E. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology. 135:1994;2662-2680.
24. Vertongen P., Schiffmann S.N., Gourlet P., Robberecht P. Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Peptides. 18:1997;1547-1554.